Blog list

Betalight PDT offers a promising new light-based therapy that restores meibomian gland health and provides lasting relief for dry eye sufferers.

AI is reshaping cataract surgery and optometry, but clinicians caution that it should support—not replace—professional judgment for safe, effective care.

DOT lenses are now protecting one million kids from nearsighted progression—discover how this myopia management tool works and why it’s gaining momentum.

AR technology is helping adults with amblyopia where traditional treatments couldn't—discover how enhanced training can reinvigorate vision.

Discover how retinal scans, interpreted by AI, can help detect serious systemic diseases early—ushering in a new era of preventive eye-centered healthcare.

VIZZ becomes the first aceclidine-based eye drop approved for presbyopia, promising near-vision clarity without glasses for up to 10 hours. Discover how it works and why it's a game-changer.

New AR and robotic tools are transforming oculoplastic surgery. Learn how real-time imaging and robotic guidance are improving safety and outcomes in eyelid and orbital procedures.

In 2025, Encelto became the first approved gene therapy implant for MacTel Type 2, offering a pioneering, one-time treatment to safeguard central vision in this rare retinal disease.

Fumagillin—a fungal-derived topical antibiotic—has treated a rare corneal infection without surgery in pilot cases, offering hope for less invasive eye care options.

Virtual eye models created with AI and imaging could transform vision therapy by predicting outcomes on a digital twin before real-world intervention.